About Antibiotics

12 January 2026

Ceftobiprol vs combination of vancomycin and ceftazidime in the treatment of patients with complicated skin and soft tissue infections

Ceftobiprol is no less effective than the combination of vancomycin and ceftazidime in the treatment of patients with complicated skin and soft tissue infections of both gram-positive and gram-negative etiology.

11 January 2026

Protease inhibitor vs non-nucleoside reverse transcriptase inhibitor as a component of initial HAART

Highly active antiretroviral regimens that included a drug from the group of non-nucleoside reverse transcriptase inhibitors suppressed HIV activity to a greater extent than regimens that included a drug from the protease inhibitor group.

10 January 2026

Colistin inhaled for the treatment of ventilator-associated pneumonia

The review provides modern approaches to colistin dosage regimens for inhalation administration in the treatment of bacterial infections caused by multidrug-resistant strains of Pseudomonas aeruginosa, Acinetobacter baumannii and Klebsiella pneumonia.

09 January 2026

Early use of combination antibiotics improves survival for patients with septic shock

Early use of combined antibacterial therapy improves the survival of patients with septic shock in the intensive care unit and the intensive care unit (ICU).

08 January 2026

Management of patients with community-acquired pneumonia

Community-acquired pneumonia (CAP) remains the main cause of morbidity and mortality from infectious diseases in developed countries. The pneumonia severity scale is most often used to assess the severity of a patient with CAP and the need for hospitalization.

07 January 2026

The efficacy of adefovir in lamivudine-resistant hepatitis B virus infections

Adefovira dipivoxil is also effective in the treatment of chronic hepatitis B, regardless of the genotype of resistance to lamivudine.